Condition
Chronic Chagas Disease
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 3 (1)
Trial Status
Enrolling By Invitation1
Withdrawn1
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07033325Enrolling By Invitation
University-Based Chagas Testing in Salta Province, Argentina
NCT06339710Phase 3WithdrawnPrimary
Short Benznidazole Regimen for Chronic Phase Chagas Disease Patients
NCT04984616Phase 2TerminatedPrimary
Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas Disease
Showing all 3 trials